Don’t sleep on this troubling symptom of Alzheimer’s. Despite primarily affecting people over the age of 65, the most common ...

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

Scientists found that protein deposits in the retina create unique light patterns for different brain diseases in humans.

Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing rinvatercept for ALS.

Experimental therapy RT1999 will soon be tested in the UK EXPERTS-ALS platform trial designed to rapidly screen potential ALS treatments.

Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers that enable imaging of disease-related molecular biomarkers in the eye, announced today a Phase 2 grant ...

Researchers at the University of Alabama at Birmingham are working to better understand ALS and find new ways to slow or stop the disease.

Researchers have identified seven distinct types of hyperarousal (tension) linked to insomnia, ADHD, and anxiety, revolutionizing mental health diagnosis and treatment.

Balancing the potential benefits and risks of artificial intelligence (AI) in clinical diagnosis is the #1 patient safety concern for 2026 according to the annual Top 10 Patient Safety Concerns report ...

Researchers create a massive single-cell atlas of the aging mouse brain, revealing how epigenetic changes and "jumping genes" drive neurodegeneration.

A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic ...

Key combination for the treatment of Small Cell Lung Cancer MADRID and CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, ...